Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

13.42
Delayed Data
As of Apr 24
 -0.25 / -1.83%
Today’s Change
4.13
Today|||52-Week Range
13.77
+18.76%
Year-to-Date

Today’s Trading

Previous close13.67
Today’s open13.66
Day’s range13.42 - 13.77
Volume756,371
Average volume (3 months)1,373,963
Market cap$1.4B
Dividend yield--
Data as of 3:59pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)+39.39%
Earnings growth (this year)-24.17%
Earnings growth (next 5 years)+5.61%
Revenue growth (last year)+115.03%
P/E ratioNM
Price/Sales11.48
Price/Book--

Competitors

 Today’s
change
Today’s
% change
TTPHTetraphase Pharmaceu...-0.67-1.65%
INSMInsmed Inc-0.21-0.90%
ACORAcorda Therapeutics ...-0.38-1.13%
NLNKNewLink Genetics Cor...-0.90-1.70%
Data as of 4:00pm ET, 04/24/2015

Financials

Next reporting dateMay 12, 2015
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$102.8M
Annual profit (last year)-$83.3M
Net profit margin-81.06%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert J. Mulroy
Head-
Corporate Operations
William M. McClements
Corporate headquarters
Cambridge, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers